A single dose of cocaine raises SV2A density in hippocampus of adolescent rats.

adolescent autoradiography cocaine rats synaptic vesicle glycoprotein 2A (SV2A)

Journal

Acta neuropsychiatrica
ISSN: 1601-5215
Titre abrégé: Acta Neuropsychiatr
Pays: England
ID NLM: 9612501

Informations de publication

Date de publication:
27 Feb 2023
Historique:
pubmed: 28 2 2023
medline: 28 2 2023
entrez: 27 2 2023
Statut: aheadofprint

Résumé

Cocaine is a highly addictive psychostimulant that affects synaptic activity with structural and functional adaptations of neurons. The transmembrane synaptic vesicle glycoprotein 2A (SV2A) of pre-synaptic vesicles is commonly used to measure synaptic density, as a novel approach to the detection of synaptic changes. We do not know if a single dose of cocaine suffices to affect pre-synaptic SV2A density, especially during adolescence when synapses undergo intense maturation. Here, we explored potential changes of pre-synaptic SV2A density in target brain areas associated with the cocaine-induced boost of dopaminergic neurotransmission, specifically testing if the effects would last after the return of dopamine levels to baseline. We administered cocaine (20 mg/kg i.p.) or saline to rats in early adolescence, tested their activity levels and removed the brains 1 hour and 7 days after injection. To evaluate immediate and lasting effects, we did autoradiography with [ We found a significant increase of [ Cocaine provoked lasting changes of hippocampal synaptic SV2A density after a single exposure during adolescence.

Identifiants

pubmed: 36847240
pii: S0924270823000145
doi: 10.1017/neu.2023.14
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-9

Auteurs

Rachele Rossi (R)

Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Denmark.
Department of Nuclear Medicine and PET Center, Aarhus University Hospital, Aarhus, Denmark.

Simone Larsen Bærentzen (SL)

Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Denmark.
Department of Nuclear Medicine and PET Center, Aarhus University Hospital, Aarhus, Denmark.

Majken B Thomsen (MB)

Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Denmark.
Department of Nuclear Medicine and PET Center, Aarhus University Hospital, Aarhus, Denmark.

Caroline C Real (CC)

Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Denmark.
Department of Nuclear Medicine and PET Center, Aarhus University Hospital, Aarhus, Denmark.

Gregers Wegener (G)

Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Denmark.

Rodrigo Grassi-Oliveira (R)

Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Denmark.

Albert Gjedde (A)

Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Denmark.
Department of Neuroscience, University of Copenhagen, Denmark.
Department of Neurology and Neurosurgery, McGill University, Montreal, Canada.

Anne M Landau (AM)

Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Denmark.
Department of Nuclear Medicine and PET Center, Aarhus University Hospital, Aarhus, Denmark.

Classifications MeSH